Prelude Therapeutics's total assets for Q4 2024 were $175.51M, a decrease of -11.01% from the previous quarter. PRLD total liabilities were $44.06M for the fiscal quarter, a 8.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.